Abstract:In many instances, multidrug resistance (MDR) is mediated by increasing the expression at the cell surface of the MDR1 gene product, P-glycoprotein (P-gp), a 170-kD energy-dependent efflux pump. The aim of this study was to investigate the potential benefit of combination therapy with magnetic Fe(3)O(4) nanoparticle [MNP (Fe(3)O(4))] and MDR1 shRNA expression vector in K562/A02 cells. For stable reversal of "classical" MDR by short hairpin RNA (shRNA) aiming directly at the target sequence (3491-3509, 1539-1557, and 3103-3121 nucleotide) of MDR1 mRNA. PGC silencer-U6-neo-GFP-shRNA/MDR1 called PGY1-1, PGY1-2, and PGY1-3 were constructed and transfected into K562/A02 cells by lipofectamine 2000. After transfected and incubated with or without MNP (Fe(3)O(4)) for 48 hours, the transcription of MDR1 mRNA and the expression of P-gp were detected by quantitative real-time PCR and Western-blot assay respectively. Meanwhile intracellular concentration of DNR in K562/A02 cells was detected by flow cytometry (FCM). PGC silencer-U6-neo-GFP-shRNA/MDR1 was successfully constructed, which was confirmed by sequencing and PGY1-2 had the greatest MDR1 gene inhibitory ratio. Analysis of the reversal ratio of MDR, the concentration of daunorubicin (DNR) and the transcription of MDR1 gene and expression of P-gp in K562/A02 showed that combination of DNR with either MNP (Fe(3)O(4)) or PGY1-2 exerted a potent cytotoxic effect on K562/A02 cells, while combination of MNP (Fe(3)O(4)) and PGY1-2 could synergistically reverse multidrug resistance. Thus our in vitro data strongly suggested that a combination of MNP (Fe(3)O(4)) and shRNA expression vector might be a more sufficient and less toxic anti-MDR method on leukemia.

[Identification of Multidrug Resistance Related Genes in Leukemia by Suppression Subtractive Hybridization].

Screening and Cloning Multi-Drug Resistance Related Gene of Acute Myeloid Leukemia Cells

Screening and Cloning of Multi-Drug Resistant Genes in HL-60/MDR Cells.

[Overexpression of S3 Ribosomal Protein Gene is Involved in Drug Resistance in K562/DOX Cells].

[Construction and Analysis of Subtractive Cdna Library Associated with Multidrug Resistance of Acute Leukemia].

Comparative Proteomic Analysis of Differentially Expressed Proteins Between K562 and K562/ADM Cells

Spectrum of Gene Expression of a Multi-Drug Resistant Leukemia Cell Line with High Tumorigenicity in Nude Mice

Reversal of Multidrug Resistance by Magnetic Fe3o4 Nanoparticle Copolymerizating Daunorubicin and Mdr1 Shrna Expression Vector in Leukemia Cells

Detection approaches for multidrug resistance genes of leukemia

Screening and Identification of Genes Associated with Multi-Drug Resistance in Colonic Cancer

Retro viral mediated efficient transfer andexpression of multiple drug resistance gene to human leukemic cells

Proteomic Analysis on Multi-Drug Resistant Cells Hl-60/Dox of Acute Myeloblastic Leukemia

[Reversal of Mdrl Gene-Dependent Multidrug Resistance in Multidrug Resistance Human Leukemia Cell Line K562/ADM Using Short Hairpin RNA Expression Vectors].

Analysis of Novel Microrna Targets in Drug-Sensitive and -Insensitive Small Cell Lung Cancer Cell Lines.

Identification of Chemoresistance-Related Cell-Surface Glycoproteins in Leukemia Cells and Functional Validation of Candidate Glycoproteins.

Expression and Clinical Implication of Soluble Resistance-Associated Calcium-B Inding Protein Gene and Multi-Drug Resistance Gene in Leukemia

Detection of the Differential Expression of Genes Associated with Apoptosis in the Drug Resistant ALL Patiens with Cdna Microarray

[In Silicon Cloning of HV126, a Novel Human Gene Related to Multi Drug Resistance in Leukemia].

Identification of crucial genes and prediction of small molecules for multidrug resistance of Hodgkin's lymphomas.

Significance of quantification of MDR1 gene and CD56 antigen expression in acute myeloid leukemia patients

Reversal of Multidrug Resistance by MDR1 Shrna Expression Vector in Human Leukemia K562/A02cells